1. Tsuchiya R, Tsunoda T. Tumor size as a predictive factor. Int J Pancreatol 1990;7:117.
2. Satake K, Nishiwaki H, Yokomatsu H. Surgical curability and prognosis : standard resection versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 1992;175:259.
4. Yamamoto M, Ohashi O, Saitoh Y. Japan pancreatic cancer resistry : Current status. Pancreas 1998;16:238-242.
5. Demeure MJ, Doffek KM, Komorowski RA, Wilson SD. Adenocarcinoma of the pancreas : detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Cancer 1998;83:1328-1334.
6. Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas 1998;16:396-401.
7. Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma. Pancreas 1992;7:66-86.
8. Lynch HT. Genetics and pancreatic cancer. Arch Surg 1994;129:266-268.
9. Lynch HT, Fusaro L, Lynch JF. Familial pancreatic cancer. A family study. Pancreas 1992;7:511-511.
10. Comfort MW, Steinberg AG. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 1952;21:54-63.
11. Ekbom A, McLaughlin JK, Karlsson B, Nyren O, Gridley G, Fraumeri JF, et al. Pancreatitis and pancreatic cancer: A population-based study. J Natl Cancer Inst 1994;86:625-627.
12. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, DiFrancesco V, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993;328:1433-1437.
13. McKusick VA. Mendelian inheritance in man 1990;Baltimore: Johns Hopkins University Press.
14. Satake K, Takeuchi T, Homma T, et al. Ca 19-9 as a screening and diagnostic tool in symptomatic patients : The Japanese experience. Pancreas 1994;9:703-706.
15. Matsumoto S, Harada H, Tanaka J, Ochi K, Seno T, Kunichika K, et al. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages. Pancreas 1994;9:741-747.
16. Bang SM, Chung HW, Park SW, Chung JB, Kang JK, Song SY, et al. The usefulness of 18 FDG-PET scan in determination of treatment response in pancreatic cancer. Gastroenterology 2003;124:Suppl 1. A-188.
17. Burris HA 3rd, Moore MJ, Andersen J, Green HR, Rothenberg ML, Van Hoty DD, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : a randomized trial. J Clin Oncol 1997;15:2403-2413.
18. Chung HW, Park JY, Kim SA, Shin Y, Park SW, Song SY, et al. Comparison of concurrent chemoradiation between paclitaxel/furtulon and gemcitabine/furtulon for the locally advanced pancreatic carcinoma. Gastroenterology 2002;122:Suppl 1. A-337.